ATE324145T1 - Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält - Google Patents
Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthältInfo
- Publication number
- ATE324145T1 ATE324145T1 AT02714140T AT02714140T ATE324145T1 AT E324145 T1 ATE324145 T1 AT E324145T1 AT 02714140 T AT02714140 T AT 02714140T AT 02714140 T AT02714140 T AT 02714140T AT E324145 T1 ATE324145 T1 AT E324145T1
- Authority
- AT
- Austria
- Prior art keywords
- paclitaxel
- medicine containing
- containing substituted
- substituted pyrroles
- anticancer medicine
- Prior art date
Links
- 229930012538 Paclitaxel Chemical class 0.000 title 1
- 230000001093 anti-cancer Effects 0.000 title 1
- 229960001592 paclitaxel Drugs 0.000 title 1
- 150000003233 pyrroles Chemical class 0.000 title 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical class O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26787401P | 2001-02-09 | 2001-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE324145T1 true ATE324145T1 (de) | 2006-05-15 |
Family
ID=23020488
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02714140T ATE324145T1 (de) | 2001-02-09 | 2002-02-01 | Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6548531B2 (de) |
| EP (1) | EP1359979B1 (de) |
| JP (1) | JP4128872B2 (de) |
| KR (1) | KR100542069B1 (de) |
| CN (1) | CN1265786C (de) |
| AR (2) | AR035429A1 (de) |
| AT (1) | ATE324145T1 (de) |
| AU (1) | AU2002246080B2 (de) |
| BR (1) | BR0206954A (de) |
| CA (1) | CA2435921C (de) |
| DE (1) | DE60210926T2 (de) |
| DK (1) | DK1359979T3 (de) |
| ES (1) | ES2261648T3 (de) |
| MX (1) | MXPA03007036A (de) |
| PT (1) | PT1359979E (de) |
| WO (1) | WO2002064214A2 (de) |
| ZA (1) | ZA200305967B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2440555A1 (en) * | 2001-03-14 | 2002-09-19 | Bristol-Myers Squibb Company | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| WO2002094271A1 (en) * | 2001-05-15 | 2002-11-28 | Faulk Pharmaceuticals, Inc. | Targeted delivery of bioaffecting compounds for the treatment of cancer |
| WO2002092116A1 (en) * | 2001-05-15 | 2002-11-21 | Faulk Pharmaceuticals, Inc. | Targeted delivery of drugs for the treatment of viral infections |
| WO2002102373A1 (en) * | 2001-06-15 | 2002-12-27 | F. Hoffmann-La Roche Ag | Method for administration of cancer therapeutic |
| US20030139373A1 (en) * | 2001-11-20 | 2003-07-24 | Breimer Lars Holger | Method for cancer therapy |
| CA3054535A1 (en) | 2005-02-18 | 2006-08-24 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US8735394B2 (en) * | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| EP2552415B1 (de) | 2010-03-29 | 2016-09-07 | Abraxis BioScience, LLC | Verfahren zur behandlung von karzinomen |
| MX2012011155A (es) | 2010-03-29 | 2012-12-05 | Abraxis Bioscience Llc | Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos. |
| NZ706745A (en) | 2010-06-04 | 2017-01-27 | Abraxis Bioscience Llc | Methods of treatment of pancreatic cancer |
| TW201613576A (en) | 2014-06-26 | 2016-04-16 | Novartis Ag | Intermittent dosing of MDM2 inhibitor |
| KR102325778B1 (ko) | 2016-11-15 | 2021-11-12 | 노파르티스 아게 | HDM2-p53 상호작용 억제제에 대한 용량 및 요법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227850A (en) | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
| US6080777A (en) * | 1992-01-31 | 2000-06-27 | The Trustees Of Columbia University In The City Of New York | Taxol as a radiation sensitizer |
| CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
| JPH08500112A (ja) * | 1992-08-12 | 1996-01-09 | ジ・アップジョン・カンパニー | タキソールと組み合わせるプロテインキナーゼ阻害剤および関連化合物 |
| PT1064279E (pt) | 1998-03-17 | 2003-10-31 | Hoffmann La Roche | Bisindolilmaleimidas substituidas para a inibicao da proliferacao celular |
| EP1071414A1 (de) * | 1998-04-24 | 2001-01-31 | Mitokor | Verbindungen und verfahren zur behandlung von mitochondrialererkrankungen |
| US6277844B1 (en) * | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6335194B1 (en) * | 1998-09-29 | 2002-01-01 | Isis Pharmaceuticals, Inc. | Antisense modulation of survivin expression |
-
2002
- 2002-01-23 US US10/055,451 patent/US6548531B2/en not_active Expired - Lifetime
- 2002-02-01 AU AU2002246080A patent/AU2002246080B2/en not_active Expired
- 2002-02-01 DK DK02714140T patent/DK1359979T3/da active
- 2002-02-01 JP JP2002564006A patent/JP4128872B2/ja not_active Expired - Lifetime
- 2002-02-01 ES ES02714140T patent/ES2261648T3/es not_active Expired - Lifetime
- 2002-02-01 WO PCT/EP2002/001042 patent/WO2002064214A2/en active IP Right Grant
- 2002-02-01 PT PT02714140T patent/PT1359979E/pt unknown
- 2002-02-01 EP EP02714140A patent/EP1359979B1/de not_active Expired - Lifetime
- 2002-02-01 CA CA002435921A patent/CA2435921C/en not_active Expired - Lifetime
- 2002-02-01 KR KR1020037010445A patent/KR100542069B1/ko active IP Right Grant
- 2002-02-01 DE DE60210926T patent/DE60210926T2/de not_active Expired - Lifetime
- 2002-02-01 CN CNB028047516A patent/CN1265786C/zh not_active Expired - Lifetime
- 2002-02-01 BR BR0206954-7A patent/BR0206954A/pt not_active Application Discontinuation
- 2002-02-01 MX MXPA03007036A patent/MXPA03007036A/es active IP Right Grant
- 2002-02-01 AT AT02714140T patent/ATE324145T1/de active
- 2002-02-07 AR ARP020100400A patent/AR035429A1/es not_active Application Discontinuation
-
2003
- 2003-08-01 ZA ZA2003/05967A patent/ZA200305967B/en unknown
-
2014
- 2014-12-12 AR ARP140104645A patent/AR098745A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1265786C (zh) | 2006-07-26 |
| BR0206954A (pt) | 2004-02-25 |
| PT1359979E (pt) | 2006-08-31 |
| DK1359979T3 (da) | 2006-08-28 |
| JP2004517961A (ja) | 2004-06-17 |
| EP1359979A2 (de) | 2003-11-12 |
| WO2002064214A2 (en) | 2002-08-22 |
| US6548531B2 (en) | 2003-04-15 |
| AR098745A2 (es) | 2016-06-08 |
| KR100542069B1 (ko) | 2006-01-11 |
| CA2435921A1 (en) | 2002-08-22 |
| US20020156118A1 (en) | 2002-10-24 |
| WO2002064214A3 (en) | 2003-05-30 |
| ZA200305967B (en) | 2005-01-26 |
| CA2435921C (en) | 2009-12-22 |
| MXPA03007036A (es) | 2003-11-18 |
| DE60210926D1 (de) | 2006-06-01 |
| CN1491126A (zh) | 2004-04-21 |
| AR035429A1 (es) | 2004-05-26 |
| KR20040025894A (ko) | 2004-03-26 |
| DE60210926T2 (de) | 2007-01-11 |
| WO2002064214A8 (en) | 2004-02-19 |
| ES2261648T3 (es) | 2006-11-16 |
| JP4128872B2 (ja) | 2008-07-30 |
| AU2002246080B2 (en) | 2006-08-10 |
| EP1359979B1 (de) | 2006-04-26 |
| AU2002246080C1 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG25614A (en) | Novel pyrroles derivatives as pharmaceutical agents | |
| EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
| DE60044069D1 (de) | Chromenverbindung und diese enthaltende Artikel | |
| CY2014008I1 (el) | Παραγωγα κιναζολινης, φαρμακα που περιεχουν τις ενωσεις αυτες χρηση αυτων και μεθοδους για την παραγωγη τους | |
| EE200200357A (et) | Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid | |
| NO20006630D0 (no) | Farmasöytisk sammensetning for behandlingen av diabetes | |
| HUP0401718A3 (en) | Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them | |
| ATE438639T1 (de) | 2-cyanopyrrolidin-derivate und ihre verwendung als arzneimittel | |
| ATE401859T1 (de) | Vorrichtungen zur verabreichung von arzneistoffen mit antiprogestinischen eigenschaften | |
| DK1400518T3 (da) | Heterocycliske forbindelser og lægemidler | |
| DE60023792D1 (de) | Karmin und Karamel enthaltende selbstbräunende Zusammensetzung | |
| IL158523A0 (en) | Epothilone derivatives and pharmaceutical compositions containing the same | |
| EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
| EE200200607A (et) | 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena | |
| ATE324145T1 (de) | Antikrebs-heilmittel welche substituierte pyrrole und paclitaxel enthält | |
| ATE320256T1 (de) | Succinate des 5,8,14-triazatetracyclo(10.3.1.0 2, 11 .0 4,9 )-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
| IL157908A0 (en) | Phthalazinone derivatives and pharmaceutical compositions containing the same | |
| ATE350016T1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| HUP0302648A3 (en) | Bicyclic heteroaromatic compounds, pharmaceutical compositions containing them and their use | |
| AU2002365665A1 (en) | Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours | |
| AU2002347360A1 (en) | Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours | |
| ATE272641T1 (de) | Neue xanthon derivate, deren herstellung und verwendung als arzneimittel | |
| PT1289514E (pt) | Utilizacao de compostos 1-amino-5-fenilpentano-3-ol e/ou 1-amino-6-fenil-hexano-3-ol substituidos como medicamentos | |
| ATE338548T1 (de) | Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen | |
| HUP0203558A3 (en) | Substituted pyrroles as antiproliferative compounds for the treatment of cancer and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1359979 Country of ref document: EP |